Hologic (HOLX) has shown a 2% rise in the past week, sparking investor interest, despite numerous share sales such as that of
Sumitomo Mitsui Trust Holdings Inc. who sold 8947 shares. It's anticipated that Hologic will announce their financial results for the third quarter of fiscal 2024 on Monday,
July 29, 2024. Investment firms, such as
First Trust Direct Indexing L.P., have increased their stock position in Hologic, indicating positive sentiments about the company's market potential. However, the market seem to be outperforming the
Hologic (HOLX) stock which has dipped even as the market gains. Denali Advisors LLC and the State of Michigan Retirement System have both reduced shares of Hologic. There are fresh investments into the company, such as from
Norden Group LLC and
Mather Group LLC. Even while facing losses, Hologic outperforms competitors and Q2 fiscal earnings and revenues for 2024 surpassed estimates. The stock has seen a reduced price target
at $76.00 by Evercore ISI. However, analysts still believe it to be a good investment, with the company receiving an average 'Moderate Buy' rating by brokerages. The company looks set for expansion, with possibility of M&A highlighted by an analyst.
Hologic HOLX News Analytics from Thu, 07 Mar 2013 08:00:00 GMT to Sun, 07 Jul 2024 10:44:20 GMT -
Rating 1
- Innovation 2
- Information 7
- Rumor -5
